http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05216280-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be92719b856db86c092cc233e9512ca2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G9-097
filingDate 1992-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23017d3e276497800367301a523fe53c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb28c1e566a74532d18dac28c50eee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057e55e8ebd0a8fd4816620ab112bfc4
publicationDate 1993-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05216280-A
titleOfInvention Negatively charging toner for developing electrostatic image and developing method
abstract (57) [Summary] [Structure] A quaternary ammonium salt compound or quaternary phosphonium salt compound containing a binder resin, a colorant, and a negative charge control agent as main components, and the negative charge control agent having a specific structure. And a developing method using the same. [Effects] When this toner is applied to an image forming method using a non-magnetic one-component developing method, a sufficiently charged toner can be uniformly carried on a developer carrier, and can be stably transported to a developing area, and the developer can be carried. The filming of the toner on the body is controlled, and a high-density and high-quality image can be obtained for a long time.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546051-B2
priorityDate 1992-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450326739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451346688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449029786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448709835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID186342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID143646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452967367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3670169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447756586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416391341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3935589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410119169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450937109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49868115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135871623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448333909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454007995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415842417

Total number of triples: 48.